Systemic Codelivery of Thymoquinone and Doxorubicin by Targeted Mesoporous Silica Nanoparticle Sensitizes Doxorubicin-Resistant Breast Cancer by Interfering between the MDR1/P-gp and miR 298 Crosstalk
ACS Biomaterials Science & Engineering · 2024
DOI: 10.1021/acsbiomaterials.4c01081 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2024. Verfasst von Mousumi Bhattacharjee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata, West Bengal 7…. Hauptthemen laut MEDLINE: Doxorubicin, Drug Resistance, Neoplasm, Breast Neoplasms, Silicon Dioxide. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Ministry of AYUSH, Government of India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Research in Nanoscience and Nanotechnology, Technology Campus, University of Calcutta, JD-2, Sector-III, Salt Lake, Kolkata, West Bengal 700106, India.
- Department of Physiology, University of Calcutta, 92 Acharya Prafulla Chandra Road, Kolkata, West Bengal 700009, India.
- Department of Life Science and Biotechnology, Jadavpur University, 188, Raja Subodh Chandra Mallick Rd, Jadavpur, Kolkata, West Bengal 700032, India.
- Amity Institute of Biotechnology, Amity University, Rajarhat, New Town, Kolkata, West Bengal 700135, India.
ORCID-Profile: Avijit Ghosh, Saurav Bhattacharya, Arghya Adhikary
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
- Ministry of AYUSH, Government of India
Zitieren
APA
Bhattacharjee, M., Ghosh, A., Das, S., Sarker, S., Bhattacharya, S., Das, A., Ghosh, S., Chattopadhyay, S., Ghosh, S., & Adhikary, A. (2024). Systemic Codelivery of Thymoquinone and Doxorubicin by Targeted Mesoporous Silica Nanoparticle Sensitizes Doxorubicin-Resistant Breast Cancer by Interfering between the MDR1/P-gp and miR 298 Crosstalk. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.4c01081
Vancouver
Bhattacharjee M, Ghosh A, Das S, Sarker S, Bhattacharya S, Das A, et al. Systemic Codelivery of Thymoquinone and Doxorubicin by Targeted Mesoporous Silica Nanoparticle Sensitizes Doxorubicin-Resistant Breast Cancer by Interfering between the MDR1/P-gp and miR 298 Crosstalk. ACS Biomaterials Science & Engineering. 2024. doi:10.1021/acsbiomaterials.4c01081
BibTeX
@article{Bhattacharjee2024,
author = {Bhattacharjee, Mousumi and Ghosh, Avijit and Das, Shaswati and Sarker, Sushmita and Bhattacharya, Saurav and Das, Ankur and Ghosh, Subhajit and Chattopadhyay, Sreya and Ghosh, Swatilekha and Adhikary, Arghya},
title = {Systemic Codelivery of Thymoquinone and Doxorubicin by Targeted Mesoporous Silica Nanoparticle Sensitizes Doxorubicin-Resistant Breast Cancer by Interfering between the MDR1/P-gp and miR 298 Crosstalk},
journal = {ACS Biomaterials Science & Engineering},
year = {2024},
doi = {10.1021/acsbiomaterials.4c01081}
}
EUVIMED